The DNA fragmentation factor (DFF) is composed of two subunits, the 40-kDa caspase-3-activated nuclease (DFF40/CAD) and its 45-kDa inhibitor (DFF45/ICAD). 
The DNA fragmentation factor (DFF) is composed of two subunits, the 40-kDa caspase-3-activated nuclease (DFF40/CAD) and its 45-kDa inhibitor (DFF45/ICAD). During apoptosis, DFF-40/CAD is activated by caspase-3-mediated cleavage of DFF45/ICAD. Mutational analysis of DFF40/CAD revealed that DFF40/CAD is composed of a C-terminal catalytic domain and an N-terminal regulatory domain. Deletion of the catalytic domain (residues 290 -345) abrogated the caspase-3-induced nuclease activity of DFF40/CAD but not its ability to interact with DFF45/ICAD. Conversely, removal of the regulatory domain (residues 1-83) yielded a constitutively active DFF40/CAD nuclease that neither bound to its inhibitor nor required caspase-3 for activation. Amino acid alignment revealed that the regulatory domain of DFF40/ CAD has homology to the N-terminal region of mammalian and Drosophila DFF45/ICAD and CIDE-N, a regulatory domain previously identified in pro-apoptotic CIDE proteins. Mutational analysis of the N-terminal region revealed mutants with diminished nuclease activity but with intact ability to bind DFF45/ICAD. Thus, CIDE-N represents a new type of domain that is associated with the regulation of the apoptosis/DNA fragmentation pathway.
Apoptosis, a morphologically defined form of programmed cell death plays an essential role in animal development and tissue homeostasis (1) . Apoptotic cells undergo multiple changes including membrane blebbing, nuclear condensation, and fragmentation of genomic DNA into nucleosomal fragments. These morphological and biochemical changes are promoted by caspases, a family of cysteine proteases that are activated by apoptotic stimuli. Activated caspases can cleave multiple cytoplasmic and nuclear substrates, a process that appears to play a pivotal role in the execution phase of apoptosis (2) .
DNA fragmentation associated with apoptosis is induced by the DNA fragmentation factor (DFF) 1 , which is activated by caspases, mainly caspase-3 (3) (4) (5) (6) (7) (8) . DFF is composed of two protein subunits, a 40-kDa caspase-activated nuclease (DFF40/ CAD), also called CPAN, and its 45-kDa inhibitor (DFF45/ICAD) (3) (4) (5) (6) (7) (8) . Cleavage of DFF45/ICAD by caspase-3 releases DFF40/ CAD from its inhibitor leading to the induction of nuclease activity, nuclear condensation, and DNA fragmentation in vitro (3) (4) (5) (6) (7) (8) . However, the molecular basis for DFF40/CAD function and its regulation by DFF45/ICAD remains poorly understood.
In a previous study, we identified a conserved family of proteins named CIDEs, that include CIDE-A, CIDE-B, and Fsp27, based on amino acid homology to the N-terminal region of DFF45/ICAD (9) . Unlike DFF45/ICAD, CIDEs are pro-apoptotic proteins that induce DNA fragmentation as well as other apoptotic features such as membrane blebbing and nuclear condensation (9) . The activity of CIDEs is inhibited by DFF45/ ICAD (9) . Mutational analysis revealed that CIDEs contains two domains, CIDE-N and CIDE-C (9). The CIDE-C domain is necessary and sufficient for apoptosis, whereas CIDE-N acts as a regulatory domain required for the inhibitory activity of DFF45/ICAD (9).
Here we report that DFF40/CAD has two domains with distinct biological functions. A catalytic domain located in the C-terminal region mediates nuclease activity, whereas a regulatory domain is located in the N-terminal half of DFF40/CAD. The regulatory domain of DFF40/CAD has homology to a conserved CIDE-N domain that was previously identified in the pro-apoptotic CIDE proteins. These results identify the N-terminal region of DFF40/CAD as a conserved domain that regulates the activation and activity of this apoptosis-associated nuclease.
MATERIALS AND METHODS

Construction of Expression Plasmids-
The entire cDNA open reading frame of mouse DFF40/CAD was amplified by polymerase chain reaction from cDNA synthesized from total RNA from mouse testis and cloned into the XbaI and EcoRI sites of pcDNA3-HA and pcDNA-3-Myc (9) to produce expression plasmids pcDNA3-HA-CAD and pcDNA34-Myc-CAD encoding HA-tagged and Myc-tagged DFF40/CAD, respectively. pcDNA3-Flag-DFF45, pcDNA3-caspase-9-HA, pcDNA3-TNFR1-Flag (tumor necrosis factor receptor-1), and pcDNA3-␤-gal have been previously described (9 -11) . The expression plasmids encoding deletion mutants of HA-DFF40/CAD, pcDNA3-HA-CAD⌬290 -345, pcDNA3-HA-CAD⌬162-345, and pcDNA3-Myc-CAD-⌬1-83 were constructed by polymerase chain reaction methods. The authenticity of all constructs was confirmed by dideoxy sequencing.
Transfection, Expression, and Immunodetection of Tagged Proteins-5 ϫ 10 6 human 293T cells were transfected with expression plasmids by a calcium phosphate method as described (10) . The total amount of transfected plasmid DNA was adjusted with pcDNA3 plasmid to be the same within individual experiments. 24 h post-transfection, 293T cells were harvested and lysed with 0.2% Nonidet P-40 isotonic lysis buffer (12) . Total lysates were subjected to 15% SDS-polyacrylamide electro-phoresis and immunoblotted with mAb to Flag (Kodak).
In Vitro Nuclease Assay and in Vivo DNA Fragmentation Assay-The in vitro nuclease activity was assayed with immunopurified DFF in the presence or absence of recombinant caspase-3. Briefly, 5 ϫ 10 6 293T cells were transfected with plasmids as indicated in the figure legends. 24 h post-transfection, cells were lysed with Nonidet P-40 lysis buffer, and tagged DFF40/CAD proteins were immunoprecipitated with anti-HA or anti-Myc polyclonal antibody and protein-A-Sepharose, washed five times with Nonidet P-40 lysis buffer, and then with CPAN buffer (10 mM HEPES, 1 mM EGTA, 5 mM MgCl 2 , 50 mM NaCl, 1 mg/ml bovine serum albumin, pH 7.5) (6) . The in vitro nuclease activity of the immunoprecipitated protein was assayed by incubation in CPAN buffer with or without 50 units of recombinant caspase-3 (a gift from Margarita Garcia-Calvo, Merck) and 1 g of plasmid DNA substrate and subsequent analysis of plasmid DNA degradation by agarose gel electrophoresis, as described (6) . For assay of in vivo DNA fragmentation, genomic DNA was extracted from 2 ϫ 10 4 293T cells transfected with pcDNA3, pcDNA3-caspase-9-HA, pcDNA3-TNFR1-Flag, or DFF40/ CAD expression plasmids as indicated in the figure legends, 24 h post-transfection as described (8) . The same amount of each DNA was subjected to 1% agarose gel electrophoresis. The amount of DNA loaded was 10-fold lower than previously described (9) . The cell death assay of 293T was performed as reported (9) .
RESULTS AND DISCUSSION
The N-terminal Half of DFF40/CAD Mediates Binding to DFF45/ICAD whereas the C-terminal Region Is Required for
Nuclease Activity-To identify regions of DFF40/CAD that are important for nuclease activity, binding, and sensitivity to DFF45/ICAD, we constructed a series of plasmids to express deletion mutants of DFF40/CAD (Fig. 1A) . We transfected these expression plasmids encoding HA-tagged or Myc-tagged wild type and mutant DFF40/CAD proteins into 293T embryonic kidney cells and purified the proteins by affinity chromatography.
HA-tagged wild type and C-terminal deletion mutant DFF40/CAD proteins were co-expressed with Flag-tagged DFF45/ICAD and immunoprecipitated by anti-HA antibody. In vitro nuclease activities of these immunoprecipitated proteins -345) , or pcDNA3-HA-CAD⌬162-345 (⌬162-345) and pcDNA3-TNFR1-Flag (TNFR1) or pcDNA3-caspase-9-HA (Casp. 9) plus pcDNA3-␤-gal. To assay for in vivo DNA fragmentation, genomic DNA was extracted from 1 well of transfected cells and subjected to 1% agarose electrophoresis as described under "Materials and Methods." The percentage of apoptotic cells (apop.) was determined by the ␤-galactosidase assay using transfected cells in 3 wells as described under "Materials and Methods." Standard deviation of each percentage was less than 10%.
were measured by their ability to degrade plasmid DNA substrate in the presence or absence of caspase-3. This in vitro assay revealed that the DFF40/CAD deletion mutants ⌬290 -345 and ⌬162-345 lost their caspase-activated nuclease activity when compared with control wild type (WT) DFF40/CAD (Fig. 1B, top panel) . In contrast, both DFF40/CAD mutants retained their ability to bind to DFF45/ICAD (Fig. 1B, middle  panel) . Loss of catalytic activity was not due to differences in protein levels between wild type and mutant proteins because comparable levels of both were detected in total lysates (Fig.   1C ) and immunoprecipitates (Fig. 1B, middle panel) . In addition, the sensitivity of DFF45/ICAD to caspase-3-mediated cleavage was not affected by these mutations, as DFF45/ICAD bound to either mutant was cleaved by caspase-3 (Fig. 1B,  middle and lower panels) .
We tested next the ability of WT and mutant DFF40/CAD to promote genomic DNA fragmentation in vivo. In these experiments, we transiently transfected constructs producing WT, ⌬290 -345, ⌬162-345, or control plasmid into 293T cells. Because DFF40/CAD requires an apoptotic stimulus to be acti- vated, the cells were also transfected with plasmids producing TNFR1 or caspase-9, both of which are known to activate apoptotic cell death in 293T cells (13) . Although both caspase-9 and TNFR1 could cause DNA fragmentation, we loaded a reduced amount of genomic DNA in the in vivo DNA fragmentation assay to visualize the enhancement of DNA fragmentation by DFF40/CAD. In the absence of a death stimulus, neither WT DFF40/CAD nor mutant DFF40/CAD induced DNA fragmentation (Fig. 1D) . However, when the cells were co-transfected with plasmids producing TNFR1 or caspase-9, WT DFF40/CAD did promote DNA fragmentation (Fig. 1D) . In contrast to WT DFF40/CAD, the ⌬290 -345 and ⌬162-345 mutants did not induce DNA fragmentation (Fig. 1D) . Thus, the C-terminal region of DFF40/CAD is required for catalytic activity in vitro and in vivo but not for binding to DFF45/ICAD.
The N-terminal Region of DFF40/CAD Has Homology to the N Termini of DFF45/ICAD and CIDEs-DFF40/CAD exhibits no significant amino acid or structural homology to other known nuclease families (4) . Close inspection of the DFF40/ CAD amino acid sequence by the BLAST2 program, however, revealed significant amino acid homology between the regulatory domain of DFF40/CAD and the CIDE-N domain previously identified in DFF45/ICAD and CIDE proteins (Fig. 2) . The regulatory (CIDE-N) domain of DFF40/CAD showed 49 to 55% similarity with those of CIDE-A, CIDE-B, Fsp27, DFF45/ICAD, and Drosophila DREP-1, respectively (p ϭ 10 Ϫ2 -10 Ϫ5 ). Several amino acids in the CIDE-N domain of DFF40/CAD including Lys-35, Asp-54, Gly-55, Thr-56, Phe-63, and Trp-81 are conserved in the CIDE-N domains of CIDE-A, CIDE-B, Fsp27, and DREP-1 (Fig. 2) , suggesting that they are important for the function of these proteins.
Mutant Forms with Substitution of Conserved Residues in the CIDE-N Domain of DFF40/CAD Exhibit Diminished Nu-
clease Activity-To determine whether the conserved residues in the CIDE-N domain play a role in the regulation of DFF40/ CAD activity, we introduced site-directed mutations at five conserved residues of the CIDE-N domain of DFF40/CAD (Fig.  2) . Anti-HA immunoprecipitation showed that all five of these point mutants still bound to DFF45/ICAD (Fig. 3A) . However, the G55I, F63S, and W81C mutants of DFF40/CAD exhibited reduced nuclease activity in vitro (Fig. 3B) and in vivo (Fig.  3D) , whereas the K35A and T56L mutants did not. In vitro nuclease analysis of 50-fold dilutions of the immunoprecipitated DFF40/CAD proteins from Fig. 3B confirm these differences (Fig. 3C) . Immunoblotting revealed similar levels of expression of the mutants, indicating that reduced nuclease activity was not because of diminished expression (Fig. 3A) . Under our experimental conditions using the in vitro assay, DFF45/ICAD bound to either WT DFF40/CAD or any of the mutants was completely cleaved by caspase-3. 2 In addition, neither WT DFF40/CAD nor any of the mutants bound to DFF45/ICAD protein cleaved by caspase-3.
2 These data indicate that reduced nuclease activity of the mutants is not be- cause of caspase-3 insensitivity of DFF45/ICAD bound to mutant proteins or inhibition of DFF40/CAD by an interaction with cleaved DFF45/ICAD fragments.
Comparison between wild-type, site-directed mutants of DFF40/CAD and an N-terminal deletion mutant, ⌬N, that expresses residues 84 -345 of DFF40/CAD (see below) revealed that the G55I, F63S, and W81C mutants and the ⌬N mutant exhibit in vitro nuclease activities that are reduced when compared with WT DFF40/CAD (Fig. 3, B and C and Fig. 4A ). Thus, amino acids Gly-55, Phe-63, and Trp-81 appear to enhance the nuclease activity of DFF40/CAD after cleavage of DFF45/ICAD by caspase-3 but do not play an essential role in the catalysis reaction. These results suggest that the CIDE-N regulatory domain of CAD/ICAD not only mediates binding to DFF45/ ICAD but also promotes the activity of the catalytic nuclease domain located in the C-terminal region of the protein.
A Regulatory Domain Located in the N-terminal Half of DFF40/CAD-The results of the experiments shown in Fig. 1 suggested that the nuclease activity of DFF40/CAD resides in the C-terminal half of the protein. To test this hypothesis, we assessed the nuclease activity of the N-terminal deletion mutant, ⌬N. The mutant protein retained in vitro nuclease activity, although its activity was reduced compared with that of WT DFF40/CAD (Fig. 4A) . In contrast to the WT protein, the ⌬N mutant of DFF40/CAD did not bind to DFF45/ICAD (Fig. 4 , B and C), indicating that the N-terminal region of DFF40/CAD is required for binding to DFF45/ICAD. Significantly, the ⌬N mutant had constitutive nuclease activity in that it did not require caspase-3 for enzymatic activity (Fig. 4A) . These results indicate that the N-terminal region of DFF40/CAD, although dispensable for in vitro nuclease activity, has a regulatory role, as it is required both for the interaction of DFF40/ CAD with its inhibitor DFF45/ICAD and for caspase-3-dependent activation. In addition, the N-terminal domain of DFF40/CAD is required for optimal nuclease activity, suggesting that this domain regulates the activity of the catalytic C-terminal domain. Fig. 4D is a model depicting the mechanism by which DFF40/ CAD nuclease activity may be regulated during apoptosis. When DFF40/CAD is bound to DFF45/ICAD via its N-terminal region, its nuclease activity is suppressed by this interaction. Once DFF45/ICAD is cleaved by caspase-3, the N-terminal region of DFF40/CAD is released, a process that enables the N-terminal region of DFF40/CAD to then activate the C-terminal nuclease domain. Cleavage of DFF45/ICAD by caspase-3 downstream of Asp-117, which is adjacent to its CIDE-N domain, results in the release of DFF45/ICAD fragments from DFF40/CAD (3, 5) , supporting an important role for the CIDE-N domain in DFF45/ICAD function. The regulation of the CIDE-N domain of DFF40/CAD is reminiscent of that of the recently described CIDE-N domain of CIDE-A (8) . In this protein, the CIDE-N domain is required for DFF45/ICAD inhibition of CIDE-A-mediated apoptosis (8) . In addition, deletion of the CIDE-N domain results in enhanced apoptosis, supporting its role as a regulatory domain. Thus the CIDE-N domain represents a novel class of regulatory domains that can control the function of adjacent domains. In the case of DFF40/CAD, its N-CIDE domain appears to play an important role in the activation and regulation of nuclease activity.
